SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules

The pathogenesis of type 2 cardiorenal syndrome (CRS) is mostly associated with reduced cardiac output, increased central venous pressure (CVP), activation of the renin-angiotensin-aldosterone system (RAAS), inflammation, and oxidative stress. As a drug to treat diabetes, sodium-glucose transporter...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yajiao, Mao, Xinxin, Shi, Shuqing, Xu, Xia, Lv, Jiayu, Zhang, Bingxuan, Wu, Huaqin, Song, Qingqiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479647/
https://www.ncbi.nlm.nih.gov/pubmed/37674989
http://dx.doi.org/10.3389/fneph.2022.1109321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479647/
https://www.ncbi.nlm.nih.gov/pubmed/37674989
http://dx.doi.org/10.3389/fneph.2022.1109321

Ejemplares similares